rs118192161
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Geno | Mag | Summary |
|---|---|---|
| (C;C) | 0 | common in complete genomics |
| (C;T) | 3 | susceptibility to malignant hyperthermia |
| Make rs118192161(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 19 |
| Position | 38444211 |
| Gene | RYR1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs118192161 |
| dbSNP (classic) | rs118192161 |
| ClinGen | rs118192161 |
| ebi | rs118192161 |
| HLI | rs118192161 |
| Exac | rs118192161 |
| Gnomad | rs118192161 |
| Varsome | rs118192161 |
| LitVar | rs118192161 |
| Map | rs118192161 |
| PheGenI | rs118192161 |
| Biobank | rs118192161 |
| 1000 genomes | rs118192161 |
| hgdp | rs118192161 |
| ensembl | rs118192161 |
| geneview | rs118192161 |
| scholar | rs118192161 |
| rs118192161 | |
| pharmgkb | rs118192161 |
| gwascentral | rs118192161 |
| openSNP | rs118192161 |
| 23andMe | rs118192161 |
| SNPshot | rs118192161 |
| SNPdbe | rs118192161 |
| MSV3d | rs118192161 |
| GWAS Ctlg | rs118192161 |
| Max Magnitude | 3 |
| ClinVar | |
|---|---|
| Risk | rs118192161(T;T) |
| Alt | rs118192161(T;T) |
| Reference | Rs118192161(C;C) |
| Significance | Other |
| Disease | Malignant hyperthermia Central core disease not provided |
| Variation | info |
| Gene | RYR1 |
| CLNDBN | Malignant hyperthermia, susceptibility to, 1 Central core disease not provided |
| Reversed | 0 |
| HGVS | NC_000019.9:g.38934851C>T |
| CLNSRC | OMIM Allelic Variant UniProtKB (protein) |
| CLNACC | RCV000013833.4, RCV000013834.26, RCV000119625.1, |
rs118192161, aka p.Arg163Cys or p.R163C, is a SNP in the RYR1 gene leading to increased susceptibility to malignant hyperthermia when heterozygous.
23andMe name: i6017661
[PMID 8220423] Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia.
[PMID 21499247
] Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
[PMID 8592342
] Exclusion of defects in the skeletal muscle specific regions of the DHPR alpha 1 subunit as frequent causes of malignant hyperthermia.
